Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Näky vs Omzo

Näky
Graded #395

Higher grade

vs+3.3999999999999986
Omzo
Graded #459

Lower grade

The verdict

Näky takes it — 57.6/100 to 54.2/100.

Näky grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Näky is a LegitScript-approved telehealth platform offering compounded semaglutide and tirzepatide alongside an uncommon oral semaglutide drops product and a separate GLP-1 microdose program, plus NAD+ and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationNäky +11
51
40
Clinical oversightEven
76
76
Labs & monitoringEven
52
52
FulfillmentNäky +10
73
63
Contract termsEven
55
55
Näky · left barOmzo · right bar

The numbers

MetricNäkyOmzo
WeighScore57.6/10054.2/100
GradeCC
Scorecard rank#395#459
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Näky

Graded #395 · C

Strengths

  • LegitScript Approved (verifiable for benaky.com)
  • Oral semaglutide drops as a distinct product line — uncommon among compounded GLP-1 brands
  • Separate GLP-1 microdose program offered
  • Adds NAD+ and Sermorelin for patients wanting a longevity stack
  • 3-minute online assessment with a same-day treatment plan

Where it loses points

  • Ongoing monthly pricing for compounded semaglutide and tirzepatide isn't shown until intake
  • Oral semaglutide drops and microdose program pricing not disclosed
  • Legal entity and state of incorporation not disclosed
  • Pharmacy partner not named — only a generic 'USA-based FDA-regulated' claim
  • States served not listed; pricing pages return 404s
Omzo

Graded #459 · C

Strengths

  • Compounded GLP-1 (semaglutide and tirzepatide) with clinician guidance
  • Free, discreet delivery on all treatments
  • FSA/HSA eligible
  • Multi-pillar: also women's hormone, sexual health, hair, skin, and daily health

Where it loses points

  • Pricing not published on the site — shown only after the intake quiz
  • Compounding pharmacy partner not named (states only 'independent state-licensed')
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)
  • Legal entity not named; governing law given only as 'the state in which Omzo operates'

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard